Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-01-30
2007-01-30
Rao, Deepak (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S275000, C544S122000, C544S331000
Reexamination Certificate
active
10961907
ABSTRACT:
Compounds of the general formula (I)are presented which arevaluable therapeutics for the treatment of cancer and cancer related diseases.
REFERENCES:
patent: 5656644 (1997-08-01), Adams et al.
patent: 6610695 (2003-08-01), Adams et al.
patent: WO 96/18626 (1996-06-01), None
patent: WO 03/087026 (2003-10-01), None
Herynk et al., Medline Abstract (Cancer Research, vol. 63, Issue 11, pp. 2990-2996) Jun. 2003.
Simone, Oncoloy: Introduction, Cecil Textbook of Medicine, 20thEdition, vol. 1, pp. 1004-1010, 1996.
Traxler, Protein Tyrosine Kinase Inhibitors in cancer treatment, Exp. Opin. Ther. Patents, 7(6):571-588, 1997.
Von Hirschheydt et al., Synthesis, 12, pp. 2062-2065 (2004).
Honold Konrad
Scheiblich Stefan
von Hirschheydt Thomas
Voss Edgar
Hoffmann-La Roche Inc.
Johnston George W.
Rao Deepak
Remy Brian C.
Rocha-Tramaloni Patricia S.
LandOfFree
Imidazole derivatives and their use as pharmaceutical agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Imidazole derivatives and their use as pharmaceutical agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Imidazole derivatives and their use as pharmaceutical agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3805674